Am Fam Physician

1. WILLIAMSON MLC PHD, Frutiger K PhD, Terry DL PhD
   Cognitive Behavior Therapy.
   Am Fam Physician. 2026;114:272-280.
   

   >> Share

   
   

   
   Chin J Integr Med

2. ZHANG SD, He JY, Zhang BR, Li KP, et al
   Liangfu Pill Alleviates Constipation-Predominant Irritable Bowel Syndrome through Modulation of 5-HT Signaling Pathway and Gut Microbiota.
   Chin J Integr Med. 2026 Sep 22. doi: 10.1007/s11655-026-3867.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

3. GOYAL MK, Lee A, Shah D, Brehmer S, et al
   Managing IBS-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials.
   Clin Gastroenterol Hepatol. 2026 Sep 25:S1542-3565(26)00725.
   

   >> Share

   
   

   
   Clin Nutr

4. ENGLISH CJ
   Potential duplicate inclusion of the same starch- and sucrose-reduced diet trial in a meta-analysis of dietary interventions for irritable bowel syndrome.
   Clin Nutr. 2026;66:106788.
   

   >> Share

   
   

   
   Clin Nutr ESPEN

5. IBRAHIM F
   Rapidly Fermentable Prebiotic Substrates: Benefits, FODMAP Effects and Host Tolerance.
   Clin Nutr ESPEN. 2026 Sep 19:105130. doi: 10.1016/j.clnesp.2026.105130.
   

   >> Share

   
   

   
   Clin Transl Gastroenterol

6. KIM S, Loesch J, Short EJ, Singh P, et al
   The Associations Between Attention-Deficit/Hyperactivity Disorder Stimulant Medications and Irritable Bowel Syndrome.
   Clin Transl Gastroenterol. 2026 Sep 21. doi: 10.14309/ctg.0000000000001102.
   

   >> Share

   
   

   
   Diseases

7. SHORABAEV E, Sadanov A, Baimakhanova B, Ratnikova I, et al
   Safety and Effectiveness of Probiotic Preparations: A Contemporary Review.
   Diseases. 2026;14:316.
   

   >> Share

   
   

   
   Drug Discov Today

8. KASPRZAK Z, Jaczynska M, Jarzabek J, Salaga M, et al
   5-HT(7) receptor as a potential therapeutic target in irritable bowel syndrome: Current insights and future perspectives.
   Drug Discov Today. 2026 Sep 24:104811. doi: 10.1016/j.drudis.2026.104811.
   

   >> Share

   
   

   
   Drugs

9. PUOTI MG, Oorthuys AOJ, Vermeijden NK, Benninga MA, et al
   Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes.
   Drugs. 2026 Sep 23. doi: 10.1007/s40265-026-02376.
   

   >> Share

   
   

   
   Eur J Nutr

10. YAN R, Devine A, Lo J, Marlow E, et al
    Dietary fibre blend improves gut health in patients with irritable bowel syndrome following a low FODMAP diet: a randomised, double-blind control trial.
    Eur J Nutr. 2026;65:263.
    

    >> Share

    
    

    
    Exp Biol Med (Maywood)

11. CHENG Y, Shu Q, Wang Z, Wu J, et al
    Causal effects of gut microbiota on functional gastrointestinal disorders: a bidirectional Mendelian randomization study.
    Exp Biol Med (Maywood). 2026;251:11023.
    

    >> Share

    
    

    
    Front Genet

12. HE J, Chen J, Zhang Y, Rao Y, et al
    Development and validation of a machine learning scoring system based on multi-dimensional metabolic signatures for invasive examination triage in intestinal diseases.
    Front Genet. 2026;17:1905165.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

13. MAHDI GA, Abotaiban N, Gadelmawla AF, Alfartaj M, et al
    Melatonin Supplementation in the Management of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2026 Sep 22. doi: 10.1111/jgh.70743.
    

    >> Share

    
    

    
    Lancet

14. LIU J, Shin A
    Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings.
    Lancet. 2026 Sep 24:S0140-6736(26)01815-5. doi: 10.1016/S0140-6736(26)01815.
    

    >> Share

    
    
15. JOHNSEN PH, Juul FE, Hoff DAL, Hillestad ER, et al
    Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2026 Sep 24:S0140-6736(26)01424-8. doi: 10.1016/S0140-6736(26)01424.
    

    >> Share

    
    

    
    Lancet Reg Health West Pac

16. LI W, Jin Y, Ye Z, Ren Y, et al
    Irritable bowel syndrome and suicide risk among adolescents: a prospective cohort study.
    Lancet Reg Health West Pac. 2026;74:101984.
    

    >> Share

    
    

    
    medRxiv

17. WU W, You E, Li A, Chen J, et al
    Clinical and mechanistic responses to a music-based intervention for pain in adults with irritable bowel syndrome: Protocol for a single-arm pilot study.
    medRxiv [Preprint]. 2026 Sep 17:2026.09.11.26362754.
    

    >> Share

    
    

    
    Pain Res Manag

18. MOON H, Yoon DE, Lee IS, Chae Y, et al
    Spatial Organization of Acupoint Selection Across Pain Conditions.
    Pain Res Manag. 2026;2026:e2707225.
    

    >> Share

    
    

    
    Scand J Pain

19. LOVAS I, Landmark T, Rustoen T, Vedul-Kjelsas E, et al
    Distribution of chronic primary and secondary pain in a patient sample with psychiatric disorders.
    Scand J Pain. 2026;26.
    

    >> Share

    
    

    
    Turk J Gastroenterol

20. YU C, Wang X, Chen S
    The Microbiota-Gut-Brain Axis in Disorders of Gut-Brain Interaction: Mechanisms and Emerging Therapeutic Strategies.
    Turk J Gastroenterol. 2026 Sep 15. doi: 10.5152/tjg.2026.25517.
    

    >> Share

    
    

    
    Value Health

21. APPUTHURAI P, Palsson OS, Bangdiwala SI, Sperber AD, et al
    CONFIRMATORY VALIDATION AND CLUSTER CLASSIFICATION OF THE IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS-SSS).
    Value Health. 2026 Sep 23:S1098-3015(26)05755-4. doi: 10.1016/j.jval.2026.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share